K.J. Harrison & Partners’s Clarus Therapeutics Holdings, Inc. Warrants CRXTW Stock Holding History

K.J. Harrison & Partners’s Portfolio CRXTW Stock Details CRXTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-13,000	Closed	-$1K	–	265
2022 Q2	$1K	Hold	13,000	–	–	﹤0.01%	246
2022 Q1	$2K	Hold	13,000	–	–	﹤0.01%	321
2021 Q4	$4K	Hold	13,000	–	–	﹤0.01%	379
2021 Q3	$10K	Hold	13,000	–	–	﹤0.01%	362
2021 Q2	$10K	Hold	13,000	–	–	﹤0.01%	349
2021 Q1	$7K	Buy	+13,000	New	+$10.4K	﹤0.01%	336

Other funds holding CRXTW

MSU

Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return

K.J. Harrison & Partners's CRXTW Position: Q3 2022 in Review

K.J. Harrison & Partners sold out of Clarus Therapeutics Holdings, Inc. Warrants (CRXTW) in Q3 2022, closing a stake of 13,000 shares — an estimated $1K sold.

K.J. Harrison & Partners first reported a position in CRXTW in Q1 2021 and held it in 6 quarters. The position peaked at $10K in Q3 2021. 5 funds tracked by Wall St. Rank hold CRXTW as of Q3 2022.

K.J. Harrison & Partners reported no remaining Clarus Therapeutics Holdings, Inc. Warrants position as of Q3 2022 after selling out during the quarter.
K.J. Harrison & Partners sold 13,000 Clarus Therapeutics Holdings, Inc. Warrants shares in Q3 2022, an estimated $1K.
K.J. Harrison & Partners first reported a position in Clarus Therapeutics Holdings, Inc. Warrants in Q1 2021 and held it in 6 quarters.
K.J. Harrison & Partners's Clarus Therapeutics Holdings, Inc. Warrants position peaked at $10K in Q3 2021.
5 funds tracked by Wall St. Rank held Clarus Therapeutics Holdings, Inc. Warrants as of Q3 2022.

Based on K.J. Harrison & Partners's 13F filing for Q3 2022, filed 21 Oct 2022.